Plain-English translation of NCT06598241 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is observing how Mirragen (a borate-based bioactive glass fiber matrix) performs when used to treat diabetic foot ulcers that have progressed to involve bone infection (chronic osteomyelitis). Researchers want to understand how safe and effective this already-approved wound dressing is in everyday clinical practice, gathering real-world data from patients like you who are already scheduled to receive this treatment.
Diabetic foot ulcers with bone infection are serious and slow to heal. While this medication is already available and approved, doctors and patients need better information about how well it actually works in typical outpatient care settings and what risks or benefits to expect over time.
You likely qualify if…
You likely don't qualify if…
You will attend approximately 12 weekly visits to a clinic over 16 weeks or until your ulcer heals, whichever comes first. At each visit, study staff will check your wound, apply the bioactive glass fiber dressing, and monitor your progress. After your ulcer heals, you'll return for two additional follow-up visits spaced two weeks apart to confirm healing. You will continue seeing your regular doctor for diabetes care throughout the study.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Enrollment target
~20 participants
Started
September 2024
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cyaandi R Dove, DPM
The University of Texas Health Science Center at San Antonio
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.